HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- methyl- 4- (1- methylpyrrol- 2- yl)- 4- piperidinol

structure given in first source

Also Known As:

1-MMPP; 4-Piperidinol, 1-methyl-4-(1-methyl-1H-pyrrol-2-yl)-

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol: 2

Related Diseases

1.	Dehydration (Water Stress) 01/01/1990 - "Studies of the in vitro oxidation of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol and its dehydration product 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl) pyridine by human monoamine oxidases A and B." 01/01/1990 - "The ability of highly purified preparations of human monoamine oxidase A and B (MAO A and B) to utilize 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP) and its dehydration product 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl) pyridine (TMMP) as substrates was investigated. "
2.	Hypokinesia (Bradykinesia) 03/19/1986 - "A neurologic deficit characterized by hypokinesia, postural flexion, and to a lesser extent, rigidity, tremor and myoclonus, has been observed in cynomolgus monkeys following administration of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP), a novel 4-substituted piperidine. "
3.	Tremor (Tremors) 03/19/1986 - "A neurologic deficit characterized by hypokinesia, postural flexion, and to a lesser extent, rigidity, tremor and myoclonus, has been observed in cynomolgus monkeys following administration of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP), a novel 4-substituted piperidine. "
4.	Neurologic Manifestations (Neurological Manifestations) 03/19/1986 - "A neurologic deficit characterized by hypokinesia, postural flexion, and to a lesser extent, rigidity, tremor and myoclonus, has been observed in cynomolgus monkeys following administration of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP), a novel 4-substituted piperidine. "
5.	Myoclonus (Nocturnal Myoclonus) 03/19/1986 - "A neurologic deficit characterized by hypokinesia, postural flexion, and to a lesser extent, rigidity, tremor and myoclonus, has been observed in cynomolgus monkeys following administration of 1-methyl-4-(1-methylpyrrol-2-yl)-4-piperidinol (MMPP), a novel 4-substituted piperidine. "

Related Drugs and Biologics

1.	Oxidoreductases (Dehydrogenase)
2.	pyridine
3.	magnesium monoperoxyphthalate
4.	Monoamine Oxidase (MAO)
5.	human monoamine oxidase A
6.	1- methyl- 4- (methylpyrrol- 2- yl)- 1,2,3,6- tetrahydropyridine
7.	piperidine